moleculefinder

Atorvastatin

C33H35FN2O5558.6 g/mol Calculated

Also called Cardyl, Hipolixan, Prevencor and Sortis.

The cholesterol-lowering statin sold as Lipitor, which became the best-selling medicine of all time. It blocks the body's own cholesterol assembly line.

Sources and notes
  • The introductionfrom sourceMoleculeFinder curated
  • Other namesfrom sourcePubChem / Wikidata
  • Formula and weightcomputedPubChem
  • 2D drawingcomputedPubChem structure, drawn by RDKit
  • 3D modelfrom sourcePubChem 3D conformerLoaded after the page has painted, and on a phone only when you ask for it; the 2D drawing shows until it arrives.

Where you encounter it

Dispensed on prescription, not sold on a shelf. Atorvastatin on the product labels we hold.

Medicines

LipitorAdded by the makerActive ingredient

Every product and list we hold

Sources and notes
  • The product labels and their strengthsfrom sourceDailyMed (FDA label)Each label lists the molecule as an ingredient, and an active ingredient at the strength shown.
  • How it gets therefrom sourceMoleculeFinder curatedEach mark is set by hand on our lists, never inferred; a label's ingredient is added by the maker. A row with no mark data says Not marked.
  • The line abovefrom sourceMoleculeFinder curatedFrom the group the molecule belongs to.

Explore its structure

Choose a part to light it up.

A carbon carrying both a C=O and an O-H, written COOH. In water it gives up that hydrogen, which is what makes the molecule an acid.

From: standard chemistry.

Sources and notes
  • The drawingcomputedPubChem structure, drawn by RDKitThe page's one shipped drawing, with the chosen part lit in amber under it.
  • The partscomputedFound by ruleEach part is found by a chemical pattern, never picked by hand atom by atom; its words say where they come from.

Compare a related molecule

Atorvastatin

Rosuvastatin

Both are statins, but rosuvastatin is more potent per unit weight and is largely not cleared by CYP3A4, so it has fewer interactions than atorvastatin.

Atorvastatin vs Rosuvastatin, side by side
Sources and notes
  • The sentencefrom sourceMoleculeFinder comparison notesThe pair's answer line.
  • The two drawingscomputedPubChem structures, drawn by RDKitThe two drawings side by side.

Properties and sources

Calculated by PubChem

Molecular formula
C33H35FN2O5
Molecular weight
558.6 g/mol
XLogP3octanol/water, log units
5
Polar surface areatopological
112 Ų
H-bond donors
4
H-bond acceptors
6
Rotatable bonds
12
Complexity
822

Reported Hazard label (GHS), ECHA via PubChem

Warning Irritant pictogram (GHS07) and Health hazard pictogram (GHS08); hazard statements H315, H319, H335, H361, H362

Reported Licence

The US Food and Drug Administration licenses Atorvastatin for human use (NDA 020702, authorized December 17, 1996), as Lipitor. Drugs@FDA

SMILESCC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=C…88 characters

PubChem CID 60823 · Wikidata Q668093 · InChIKey XUKUURHRXDUEBC-KAYWLYCHSA-N · Data refreshed

How MoleculeFinder sources and labels its data

Questions
What is Atorvastatin?
The cholesterol-lowering statin sold as Lipitor, which became the best-selling medicine of all time. It blocks the body's own cholesterol assembly line.
How toxic is Atorvastatin?
Its GHS hazard label carries the signal word Warning and the hazard pictograms Irritant and Health hazard. from source
What kind of molecule is Atorvastatin?
Atorvastatin has the formula C33H35FN2O5 and a molecular weight of 558.6 g/mol. MoleculeFinder files it under cholesterol medicines, in the prescription medicine group. from sourcefrom sourcefrom sourcefrom source
Who licenses Atorvastatin as a medicine?
The US Food and Drug Administration licenses Atorvastatin for human use (NDA 020702, authorized December 17, 1996), as Lipitor. from source
Sources and notes
  • Calculated valuescomputedPubChemComputed from the structure, so no laboratory conditions apply; complexity is PubChem's own structural score.
  • Hazard labelfrom sourceECHA via PubChemThe label combines these classifications.
  • ECHAfrom sourceAttributionSource: European Chemicals Agency, echa.europa.eu.
  • Licencefrom sourceDrugs@FDARead 2026-10-21.
  • Data refreshedfrom sourceMoleculeFinder2026-11-09

Keep exploring

Sources and notes
  • Compared side by sidefrom sourceMoleculeFinder comparison notesA molecule we compare it with on its own page.
  • The drawingscomputedPubChem structures, drawn by RDKit